BACK TO BACK LATEST NEWS, Official Website about ,all over the world latest news, Entertainment,Sports,Health,Fashion Hollywood,Bollywood ,Business,Latest Stories,Political news,Stock market news,and Hot news and more other topics
COPENHAGEN (Reuters) - Lundbeck agreed to buy Prexton Therapeutics, a specialist in treatments for brain disorders, in a deal potentially worth $1.1 billion, the Danish drugmaker said on Friday.
0 comments:
Post a Comment